Cargando…
Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients
Background: To identify the predictive factors of recurrence and survival in an unselected population of Western patients who underwent multimodal percutaneous thermal ablation (PTA) for small Hepatocellular Carcinomas (HCCs). Methods: January 2015–June 2019: data on multimodal PTA for <3 cm HCC...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072144/ https://www.ncbi.nlm.nih.gov/pubmed/32013112 http://dx.doi.org/10.3390/cancers12020313 |
_version_ | 1783506337461698560 |
---|---|
author | Hermida, Margaux Cassinotto, Christophe Piron, Lauranne Aho-Glélé, Serge Guillot, Chloé Schembri, Valentina Allimant, Carole Jaber, Samir Pageaux, Georges-Philippe Assenat, Eric Guiu, Boris |
author_facet | Hermida, Margaux Cassinotto, Christophe Piron, Lauranne Aho-Glélé, Serge Guillot, Chloé Schembri, Valentina Allimant, Carole Jaber, Samir Pageaux, Georges-Philippe Assenat, Eric Guiu, Boris |
author_sort | Hermida, Margaux |
collection | PubMed |
description | Background: To identify the predictive factors of recurrence and survival in an unselected population of Western patients who underwent multimodal percutaneous thermal ablation (PTA) for small Hepatocellular Carcinomas (HCCs). Methods: January 2015–June 2019: data on multimodal PTA for <3 cm HCC were extracted from a prospective database. Local tumor progression (LTP), intrahepatic distant recurrence (IDR), time-to-LTP, time-to-IDR, recurrence-free (RFS) and overall (OS) survival were evaluated. Results: 238 patients underwent 317 PTA sessions to treat 412 HCCs. During follow-up (median: 27.1 months), 47.1% patients had IDR and 18.5% died. LTP occurred after 13.3% of PTA. Tumor size (OR = 1.108, p < 0.001; hazard ratio (HR) = 1.075, p = 0.002) and ultrasound guidance (OR = 0.294, p = 0.017; HR = 0.429, p = 0.009) independently predicted LTP and time-to-LTP, respectively. Alpha fetoprotein (AFP) > 100 ng/mL (OR = 3.027, p = 0.037) and tumor size (OR = 1.06, p = 0.001) independently predicted IDR. Multinodular HCC (HR = 2.67, p < 0.001), treatment-naïve patient (HR = 0.507, p = 0.002) and AFP > 100 ng/mL (HR = 2.767, p = 0.014) independently predicted time-to-IDR. RFS was independently predicted by multinodular HCC (HR = 2.144, p = 0.001), treatment naivety (HR = 0.546, p = 0.004) and AFP > 100 ng/mL (HR = 2.437, p = 0.013). The American Society of Anesthesiologists (ASA) score > 2 (HR = 4.273, p = 0.011), AFP (HR = 1.002, p < 0.001), multinodular HCC (HR = 3.939, p = 0.003) and steatotic HCC (HR = 1.81 × 10(-16), p < 0.001) independently predicted OS. Conclusions: IDR was associated with tumor aggressiveness, suggesting a metastatic mechanism. Besides AFP association with LTP, IDR, RFS and OS, treatment-naïve patients had longer RFS, and multi-nodularity was associated with shorter RFS and OS. Steatotic HCC, identified on pre-treatment MRI, independently predicted longer OS, and needs to be further explored. |
format | Online Article Text |
id | pubmed-7072144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70721442020-03-19 Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients Hermida, Margaux Cassinotto, Christophe Piron, Lauranne Aho-Glélé, Serge Guillot, Chloé Schembri, Valentina Allimant, Carole Jaber, Samir Pageaux, Georges-Philippe Assenat, Eric Guiu, Boris Cancers (Basel) Article Background: To identify the predictive factors of recurrence and survival in an unselected population of Western patients who underwent multimodal percutaneous thermal ablation (PTA) for small Hepatocellular Carcinomas (HCCs). Methods: January 2015–June 2019: data on multimodal PTA for <3 cm HCC were extracted from a prospective database. Local tumor progression (LTP), intrahepatic distant recurrence (IDR), time-to-LTP, time-to-IDR, recurrence-free (RFS) and overall (OS) survival were evaluated. Results: 238 patients underwent 317 PTA sessions to treat 412 HCCs. During follow-up (median: 27.1 months), 47.1% patients had IDR and 18.5% died. LTP occurred after 13.3% of PTA. Tumor size (OR = 1.108, p < 0.001; hazard ratio (HR) = 1.075, p = 0.002) and ultrasound guidance (OR = 0.294, p = 0.017; HR = 0.429, p = 0.009) independently predicted LTP and time-to-LTP, respectively. Alpha fetoprotein (AFP) > 100 ng/mL (OR = 3.027, p = 0.037) and tumor size (OR = 1.06, p = 0.001) independently predicted IDR. Multinodular HCC (HR = 2.67, p < 0.001), treatment-naïve patient (HR = 0.507, p = 0.002) and AFP > 100 ng/mL (HR = 2.767, p = 0.014) independently predicted time-to-IDR. RFS was independently predicted by multinodular HCC (HR = 2.144, p = 0.001), treatment naivety (HR = 0.546, p = 0.004) and AFP > 100 ng/mL (HR = 2.437, p = 0.013). The American Society of Anesthesiologists (ASA) score > 2 (HR = 4.273, p = 0.011), AFP (HR = 1.002, p < 0.001), multinodular HCC (HR = 3.939, p = 0.003) and steatotic HCC (HR = 1.81 × 10(-16), p < 0.001) independently predicted OS. Conclusions: IDR was associated with tumor aggressiveness, suggesting a metastatic mechanism. Besides AFP association with LTP, IDR, RFS and OS, treatment-naïve patients had longer RFS, and multi-nodularity was associated with shorter RFS and OS. Steatotic HCC, identified on pre-treatment MRI, independently predicted longer OS, and needs to be further explored. MDPI 2020-01-29 /pmc/articles/PMC7072144/ /pubmed/32013112 http://dx.doi.org/10.3390/cancers12020313 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hermida, Margaux Cassinotto, Christophe Piron, Lauranne Aho-Glélé, Serge Guillot, Chloé Schembri, Valentina Allimant, Carole Jaber, Samir Pageaux, Georges-Philippe Assenat, Eric Guiu, Boris Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title | Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title_full | Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title_fullStr | Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title_full_unstemmed | Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title_short | Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients |
title_sort | multimodal percutaneous thermal ablation of small hepatocellular carcinoma: predictive factors of recurrence and survival in western patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072144/ https://www.ncbi.nlm.nih.gov/pubmed/32013112 http://dx.doi.org/10.3390/cancers12020313 |
work_keys_str_mv | AT hermidamargaux multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT cassinottochristophe multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT pironlauranne multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT ahogleleserge multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT guillotchloe multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT schembrivalentina multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT allimantcarole multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT jabersamir multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT pageauxgeorgesphilippe multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT assenateric multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients AT guiuboris multimodalpercutaneousthermalablationofsmallhepatocellularcarcinomapredictivefactorsofrecurrenceandsurvivalinwesternpatients |